Bridgepoint said to explore £550m bid for Advanced Medical Solutions, shares surge.
Advanced Medical Solutions surged on Friday following a report that private equity firm Bridgepoint is exploring an offer for the company that could value it at between £550m and £600m.
Source: Sharecast
According to banking sources cited by Sky News, Bridgepoint is examining a bid valuing AMS at between 270p and 280p per share, a premium of more than 30% to its current share price.
Sky said it was unclear on Friday morning whether it had made a formal approach to the board of AMS.
News of Bridgepoint's interest comes months after Montagu Private Equity abandoned its interest in a bid for the company. Inflexion, another private equity investor, had also been studying a potential offer last year.
AMS Group manufactures surgical brands including LiquiBand and Resorba.
At 1100 GMT, the shares were up 16% at 240.48p.
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
